• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一项针对终末期肾病患者的前瞻性研究中,与腹膜透析相比,血液透析开始时炎症反应增加。

Increased Inflammatory Response in Association with the Initiation of Hemodialysis Compared with Peritoneal Dialysis in a Prospective Study of End-Stage Kidney Disease Patients.

作者信息

Yong Kenneth, Dogra Gursharan, Boudville Neil, Lim Wai

机构信息

Department of Nephrology, Prince Of Wales Hospital, Sydney, Australia

School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.

出版信息

Perit Dial Int. 2018 Jan-Feb;38(1):18-23. doi: 10.3747/pdi.2017.00060. Epub 2017 Nov 2.

DOI:10.3747/pdi.2017.00060
PMID:29097485
Abstract

BACKGROUND

Large epidemiological studies have demonstrated an early survival advantage with the initiation of peritoneal dialysis (PD) compared to haemodialysis (HD). Chronic inflammation may contribute to atherosclerosis and cardiovascular (CVD) mortality in end-stage kidney disease (ESKD). We hypothesize that the initiation of HD in ESKD patients is associated with a greater inflammatory response compared with PD.

AIMS

To examine the effects of initiating HD and PD upon inflammation and CVD risk markers in ESKD patients.

METHODS

We performed a pilot prospective study on 75 predialysis CKD stage-5 subjects comparing the effects of HD and PD upon high sensitivity C-reactive protein (hsCRP), interleukin(IL)-12, IL-18 and pulse wave velocity (PWV). Study visits were conducted 3 - 6 months before (baseline) and after (follow-up) initiation of dialysis RESULTS: Thirty-nine and 36 patients were initiated on HD and PD respectively. HD patients were older than PD patients (65.1 ± 2.1 vs 57.7 ± 2.7 years; = 0.03) but had similar baseline systolic blood pressure (SBP), pulse pressure (PP), hsCRP, IL-12, IL-18, and PWV. At follow-up, HD patients had significantly increased hsCRP levels [5.2(3.7, 7.3) vs 1.7(1.0, 2.8)g/L; < 0.001] compared to PD. Follow-up blood pressure, IL-12, IL-18, and PWV were similar between groups. A significant association remained between hsCRP and HD after adjustment for age, previous CVD, and residual urine output.

CONCLUSION

The initiation of HD was associated with significantly increased hsCRP compared to PD. Further study is required to determine the plausibility of inflammation as a potential underlying contributor to the observed early mortality difference between dialysis modalities.

摘要

背景

大型流行病学研究表明,与血液透析(HD)相比,开始腹膜透析(PD)具有早期生存优势。慢性炎症可能导致终末期肾病(ESKD)患者发生动脉粥样硬化和心血管疾病(CVD)死亡。我们假设,与PD相比,ESKD患者开始HD与更大的炎症反应相关。

目的

研究开始HD和PD对ESKD患者炎症和CVD风险标志物的影响。

方法

我们对75例透析前慢性肾脏病5期患者进行了一项前瞻性试点研究,比较HD和PD对高敏C反应蛋白(hsCRP)、白细胞介素(IL)-12、IL-18和脉搏波速度(PWV)的影响。在开始透析前3 - 6个月(基线)和开始透析后(随访)进行研究访视。结果:分别有39例和36例患者开始HD和PD治疗。HD组患者比PD组患者年龄更大(65.1±2.1岁对57.7±2.7岁;P = 0.03),但基线收缩压(SBP)、脉压(PP)、hsCRP、IL-12、IL-18和PWV相似。随访时,与PD组相比,HD组患者hsCRP水平显著升高[5.2(3.7,7.3)对1.7(1.0,2.8)mg/L;P < 0.001]。两组间随访血压、IL-12、IL-18和PWV相似。在调整年龄、既往CVD和残余尿量后,hsCRP与HD之间仍存在显著关联。

结论

与PD相比,开始HD与hsCRP显著升高相关。需要进一步研究以确定炎症作为透析方式之间观察到的早期死亡率差异的潜在潜在因素的合理性。

相似文献

1
Increased Inflammatory Response in Association with the Initiation of Hemodialysis Compared with Peritoneal Dialysis in a Prospective Study of End-Stage Kidney Disease Patients.在一项针对终末期肾病患者的前瞻性研究中,与腹膜透析相比,血液透析开始时炎症反应增加。
Perit Dial Int. 2018 Jan-Feb;38(1):18-23. doi: 10.3747/pdi.2017.00060. Epub 2017 Nov 2.
2
Comparison of arterial stiffness in end‑stage renal disease patients treated with peritoneal dialysis or hemodialysis.接受腹膜透析或血液透析治疗的终末期肾病患者的动脉僵硬度比较。
Pol Arch Med Wewn. 2012;122(1-2):33-9. doi: 10.20452/pamw.1119. Epub 2011 Dec 28.
3
Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients.血液透析患者的动态脉波速度比诊室血压和动态血压更能准确预测心血管事件和全因死亡率。
Hypertension. 2017 Jul;70(1):148-157. doi: 10.1161/HYPERTENSIONAHA.117.09023. Epub 2017 May 8.
4
Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.血液透析和腹膜透析患者的透析方式与心血管死亡率比较
Adv Perit Dial. 2016;32:22-31.
5
Relationship between pulse pressure and inflammation with left ventricular diastolic dysfunction in chronic kidney disease patients.脉压与炎症与慢性肾脏病患者左心室舒张功能障碍的关系。
Intern Med J. 2019 Feb;49(2):240-247. doi: 10.1111/imj.14037.
6
The effect of hemodialysis on the body composition and cardiovascular disease markers in recently diagnosed end stage renal disease patients.血液透析对新诊断的终末期肾病患者身体成分和心血管疾病标志物的影响。
Rev Assoc Med Bras (1992). 2018 Apr;64(4):354-360. doi: 10.1590/1806-9282.64.04.354.
7
A prospective observational study comparing a non-operator dependent automatic PWV analyser to pulse pressure, in assessing arterial stiffness in hemodialysis.一项前瞻性观察性研究,比较非操作员依赖型自动脉搏波速度分析仪与脉压在评估血液透析患者动脉僵硬度方面的作用。
BMC Nephrol. 2015 Apr 23;16:62. doi: 10.1186/s12882-015-0058-9.
8
Dialysis modality and nutritional status are associated with variability of inflammatory markers.透析方式和营养状况与炎症标志物的变异性相关。
Nephrol Dial Transplant. 2016 Aug;31(8):1320-7. doi: 10.1093/ndt/gfw104. Epub 2016 May 24.
9
Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients.男性血液透析患者血清睾酮水平低、动脉僵硬度与死亡率。
Nephrol Dial Transplant. 2011 Sep;26(9):2971-7. doi: 10.1093/ndt/gfq847. Epub 2011 Mar 21.
10
Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial stiffness.慢性肾脏病患者白细胞介素-12 和白细胞介素-18 水平升高与动脉僵硬无关。
Cytokine. 2013 Oct;64(1):39-42. doi: 10.1016/j.cyto.2013.05.023. Epub 2013 Jun 15.

引用本文的文献

1
Evaluation of Inflammatory Status in Chronic Kidney Disease Patients and a Comparison Between Hemodialysis and Peritoneal Dialysis Patients.慢性肾脏病患者炎症状态的评估及血液透析与腹膜透析患者的比较
Cureus. 2024 Sep 15;16(9):e69443. doi: 10.7759/cureus.69443. eCollection 2024 Sep.
2
Peritoneal dialysis versus haemodialysis for people commencing dialysis.腹膜透析与血液透析治疗开始透析的患者。
Cochrane Database Syst Rev. 2024 Jun 20;6(6):CD013800. doi: 10.1002/14651858.CD013800.pub2.
3
Systemic Profile of Cytokines in Arteriovenous Fistula Patients and Their Associations with Maturation Failure.
动静脉瘘患者的细胞因子系统特征及其与成熟失败的关系。
Kidney360. 2022 Jan 13;3(4):677-686. doi: 10.34067/KID.0006022021. eCollection 2022 Apr 28.
4
First Characterization of ADAMTS-4 in Kidney Tissue and Plasma of Patients with Chronic Kidney Disease-A Potential Novel Diagnostic Indicator.慢性肾脏病患者肾脏组织和血浆中ADAMTS-4的首次特征分析——一种潜在的新型诊断指标
Diagnostics (Basel). 2022 Mar 7;12(3):648. doi: 10.3390/diagnostics12030648.
5
Heart Rate Variability and Long Chain -3 Polyunsaturated Fatty Acids in Chronic Kidney Disease Patients on Haemodialysis: A Cross-Sectional Pilot Study.慢性肾脏病血液透析患者的心率变异性与长链-3 多不饱和脂肪酸:一项横断面初步研究。
Nutrients. 2021 Jul 18;13(7):2453. doi: 10.3390/nu13072453.
6
The Nationwide Incidence of Retinal Vein Occlusion Following Dialysis due to End-stage Renal Disease in Korea, 2004 through 2013.2004 年至 2013 年韩国因终末期肾病行透析治疗后视网膜静脉阻塞的全国发病率。
J Korean Med Sci. 2021 Aug 2;36(30):e201. doi: 10.3346/jkms.2021.36.e201.
7
Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease.紧急启动腹膜透析与血液透析治疗慢性肾脏病患者。
Cochrane Database Syst Rev. 2021 Jan 27;1(1):CD012899. doi: 10.1002/14651858.CD012899.pub2.
8
Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients.可溶性晚期糖基化终产物受体(sRAGE)作为血液透析和腹膜透析患者死亡率的预后因素的作用。
Mediators Inflamm. 2018 Oct 15;2018:1347432. doi: 10.1155/2018/1347432. eCollection 2018.